Read the perspectives of two experts on the importance of clinicians and people with breast cancer working together to further innovation and personalise care.
A breakthrough in diagnostic testing is providing hope for patients like Enisa, who is receiving new targeted treatment to combat HER2-low breast cancer.
Explore how next-generation sequencing (NGS) and Roche’s SBX technology are tackling today’s most urgent and complex challenges to advance patients' outcomes.
At the heart of every accurate diagnosis lies pathology—the study of tissues and cells to identify the causes of diseases. The digital revolution is injecting new speed and precision into how we understand and identify diseases.
Roche has debuted its proprietary sequencing by expansion (SBX) technology, which offers an unparalleled combination of speed, accuracy, flexibility, scalability and real-time analysis.
Sequencing by expansion (SBX) technology has the potential to revolutionize the way DNA is sequenced, advancing scientific research for the future benefit of patients everywhere.
An ambitious collaboration of African researchers, governments, non-profit organisations, multilateral bodies, and the private sector seeks to accelerate genomic research on the continent.
Cybersecurity is no longer optional. It is central for new technologies to become a building block of ethical, safe, and patient-centered healthcare delivery models.
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)